Back
State Street SPDR S&P Pharmaceuticals ETF Stock Price Chart
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
50
XPH
State Street SPDR S&P Pharmaceuticals ETF
Last Price:
$55.63
Seasonality Move:
0.42%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
The current trend is moderately bearish and XPH is experiencing selling pressure, which indicates risk of future bearish movement.
State Street SPDR S&P Pharmaceuticals ETF Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.08 | Sell |
| 20-day SMA: | 56.19 | Sell |
| 50-day SMA: | 54.31 | Buy |
| 200-day SMA: | 46.21 | Buy |
| 8-day EMA: | 56 | Sell |
| 20-day EMA: | 55.86 | Sell |
| 50-day EMA: | 54.26 | Buy |
| 200-day EMA: | 48.59 | Buy |
State Street SPDR S&P Pharmaceuticals ETF Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 50.95 | Buy |
| Chaikin Money Flow: | -397022 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.48 - 56.82) | Sell |
| Bollinger Bands (100): | (47.3 - 54.84) | Buy |
State Street SPDR S&P Pharmaceuticals ETF Technical Analysis
| Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for State Street SPDR S&P Pharmaceuticals ETF Stock
Is State Street SPDR S&P Pharmaceuticals ETF Stock a Buy?
-
State Street SPDR S&P Pharmaceuticals ETF share price is 55.71 while XPH 8-day simple moving average is 56.08, which is a Sell signal.
-
The stock price of XPH is 55.71 while State Street SPDR S&P Pharmaceuticals ETF 20-day SMA is 56.19, which makes it a Sell.
-
State Street SPDR S&P Pharmaceuticals ETF 50-day simple moving average is 54.31 while XPH share price is 55.71, making it a Buy technically.
-
XPH stock price is 55.71 and State Street SPDR S&P Pharmaceuticals ETF 200-day simple moving average is 46.21, creating a Buy signal.
XPH Technical Analysis vs Fundamental Analysis
Sell
50
State Street SPDR S&P Pharmaceuticals ETF (XPH)
is a Sell
Is State Street SPDR S&P Pharmaceuticals ETF a Buy or a Sell?
-
State Street SPDR S&P Pharmaceuticals ETF stock is rated a SellThe current State Street SPDR S&P Pharmaceuticals ETF [XPH] share price is $55.71. The Score for XPH is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
State Street SPDR S&P Pharmaceuticals ETF Stock Info
Market Cap:
0
Price in USD:
55.71
Share Volume:
609.1K
State Street SPDR S&P Pharmaceuticals ETF 52-Week Range
52-Week High:
57.58
52-Week Low:
35.22
Sell
50
State Street SPDR S&P Pharmaceuticals ETF (XPH)
is a Sell
State Street SPDR S&P Pharmaceuticals ETF Share Price Forecast
-
What is the State Street SPDR S&P Pharmaceuticals ETF stock price today?The State Street SPDR S&P Pharmaceuticals ETF stock price is 55.71 USD today.
-
Will XPH stock go up or go down?State Street SPDR S&P Pharmaceuticals ETF> share price is forecast to RISE/FALL based on technical indicators
-
Is State Street SPDR S&P Pharmaceuticals ETF overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, State Street SPDR S&P Pharmaceuticals ETF is overvalued.
Is State Street SPDR S&P Pharmaceuticals ETF Stock a Buy?
-
State Street SPDR S&P Pharmaceuticals ETF share price is 55.71 while XPH 8-day exponential moving average is 56.00, which is a Sell signal.
-
The stock price of XPH is 55.71 while State Street SPDR S&P Pharmaceuticals ETF 20-day EMA is 55.86, which makes it a Sell.
-
State Street SPDR S&P Pharmaceuticals ETF 50-day exponential moving average is 54.26 while XPH share price is 55.71, making it a Buy technically.
-
XPH stock price is 55.71 and State Street SPDR S&P Pharmaceuticals ETF 200-day simple moving average is 48.59, creating a Buy signal.
Technical Analysis of State Street SPDR S&P Pharmaceuticals ETF
Should I short State Street SPDR S&P Pharmaceuticals ETF stock?
-
XPH Moving Average Covergence Divergence (MACD) indicator is 0.39, suggesting State Street SPDR S&P Pharmaceuticals ETF is a Buy
-
State Street SPDR S&P Pharmaceuticals ETF Relative Strength Index (RSI) is 50.95, which suggest State Street SPDR S&P Pharmaceuticals ETF is overbought
-
The Bollinger Bands (25) for State Street SPDR S&P Pharmaceuticals ETF is (55.48 - 56.82), which suggest State Street SPDR S&P Pharmaceuticals ETF is a Buy
-
The Bollinger Bands (100) for State Street SPDR S&P Pharmaceuticals ETF is (47.3 - 54.84), which suggest State Street SPDR S&P Pharmaceuticals ETF is a Buy
* State Street SPDR S&P Pharmaceuticals ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.